Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2012 - 2026)
Rockwell Medical's (RMTI) quarterly Change in Acquisitions & Divestments came in at $7.2 million in Q1 2026, up 140.0% YoY from $3.0 million in Q1 2025, and little changed on a QoQ basis from $7.2 million in Q4 2025.
Rockwell Medical (RMTI) Change in Acquisitions & Divestments (2012 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $7.2 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 140.0% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.4 million (up 307.76% YoY) and the FY2025 annual result came in at $16.2 million, up 708.79% from the prior year.
- Change in Acquisitions & Divestments steadied at $7.2 million in Q1 2026, from $7.2 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $12.0 million in Q1 2022 to a low of $1.8 million in Q2 2023.
- A 5-year average of $5.0 million and a median of $3.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments plunged 44.52% — and 2026, when it jumped 140.0%.
- Tracing RMTI's Change in Acquisitions & Divestments over 5 years: stood at $7.2 million in 2022, then sank by 44.52% to $4.0 million in 2023, then plunged by 49.92% to $2.0 million in 2024, then jumped by 259.46% to $7.2 million in 2025, then changed by 0.0% to $7.2 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $7.2 million (Q1 2026), $7.2 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.20 Mn |
| Jun 30, 2026 | 7.20 Mn |
| Mar 31, 2026 | 7.20 Mn |
| Mar 31, 2026 | 7.20 Mn |
| Dec 31, 2025 | 7.20 Mn |
| Dec 31, 2025 | 7.20 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.80 Mn |